サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1159300

婦人科健診の世界市場（2022年～2028年）

Women's Health Diagnostics Market 2022-2028
出版日: | 発行: Orion Market Research | ページ情報: 英文 170 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
婦人科健診の世界市場（2022年～2028年）
出版日: 2022年10月15日
発行: Orion Market Research
ページ情報: 英文 170 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の婦人科健診の市場規模は、予測期間中に7.5%の大幅なCAGRで成長すると予測されています。市場の成長を後押しする主な要因には、主要企業による投資の増加などが挙げられます。

当レポートでは、世界の婦人科健診市場を調査しており、市場の概要、市場動向の分析、タイプ別・用途別・エンドユーザー別・地域別の分析、競合情勢、さらに主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と見解

  • 調査範囲
  • アナリストの見解と現在の市場動向

第3章 競合情勢

  • F. Hoffmann-La Roche Ltd
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の開発
  • General Electric Co.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の開発
  • Hologic, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の開発
  • PerkinElmer Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の開発
  • Siemens Medical Solutions USA, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の開発
  • 主要戦略分析
  • 主要企業へのCOVID-19の影響

第4章 市場セグメンテーション

  • 世界の婦人科健診市場：タイプ別
    • 診断装置
    • 診断検査
  • 世界の婦人科健診市場：用途別
    • 乳がん検査
    • PAPスメア（PAP）・HPV検査
    • 感染症検査
    • 骨粗鬆症検査
    • 妊娠・不妊検査
    • 性感染症検査
    • その他
  • 世界の婦人科健診市場：エンドユーザー別
    • 在宅医療
    • 病院・診療所
    • 診断・画像センター

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • その他の地域

第6章 企業プロファイル

  • Abbott Laboratories
  • Becton, Dickinson and Co
  • BIOMERIEUX, INC.
  • Bio-Rad Laboratories, Inc.
  • BOSTON IMAGING
  • Canon Medical Systems Corp.
  • Carestream Health, Inc.
  • Cook Group Inc
  • DiaSorin S.p.A
  • Grifols, S.A.
  • Konica Minolta Healthcare Americas, Inc.
  • Laboratory Corp.
  • Myriad Genetics, Inc.
  • MedGyn Products, Inc.
  • Ortho Clinical Diagnostics
  • Philips International B.V.,
  • Quest Diagnostics
  • Thermo Fisher Scientific Inc.
  • Ziehm Imaging GmbH
図表

LIST OF TABLES

  • 1. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL WOMEN'S HEALTH DIAGNOSTICS DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

3. GLOBAL WOMEN'S HEALTH DIAGNOSTICS TESTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)

  • 4. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 5. GLOBAL BREAST CANCER TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

6. GLOBAL PAP SMEAR (PAP) AND HPV TEST IN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)

7. GLOBAL PREGNANCY AND FERTILITY TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)

8. GLOBAL SEXUALLY TRANSMITTED DISEASE TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)

  • 9. GLOBAL INFECTIOUS DISEASE TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL OSTEOPOROSIS TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL OTHERS WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 13. GLOBAL WOMEN'S HEALTH DIAGNOSTICS IN HOME CARE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 14. GLOBAL WOMEN'S HEALTH DIAGNOSTICS IN HOSPITALS & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 15. GLOBAL WOMEN'S HEALTH DIAGNOSTICS IN DIAGNOSTIC AND IMAGING CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 16. NORTH AMERICAN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 17. NORTH AMERICAN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY Dignostic device, 2021-2028 ($ MILLION)
  • 18. NORTH AMERICAN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TEST, 2021-2028 ($ MILLION)
  • 19. NORTH AMERICAN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 20. EUROPEAN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 21. EUROPEAN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIGNOSTIC DEVICE, 2021-2028 ($ MILLION)
  • 22. EUROPEAN WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TEST, 2021-2028 ($ MILLION)
  • 23. EUROPEAN WOMEN'S HEALTH DIAGNOSTICSMARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 24. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICSMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 25. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIGNOSTIC DEVICE, 2021-2028 ($ MILLION)
  • 26. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICSMARKET RESEARCH AND ANALYSIS BY TEST, 2021-2028 ($ MILLION)
  • 27. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 28. REST OF THE WORLD WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 29. REST OF THE WORLD WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIGNOSTIC DEVICE, 2021-2028 ($ MILLION)
  • 30. REST OF THE WORLD WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TEST,2021-2028 ($ MILLION)
  • 31. REST OF THE WORLD WOMEN'S HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER,2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET, 2021-2028 (%)
  • 4. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 5. GLOBAL WOMEN'S HEALTH DIAGNOSTICS DEVICES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL WOMEN'S HEALTH DIAGNOSTICS TESTSMARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 8. GLOBAL BREAST CANCER TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL PAP SMEAR (PAP) AND HPV TEST IN WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY, 2021 VS 2028 (%)
  • 10. GLOBAL PREGNANCY AND FERTILITY TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 11. GLOBAL INFECTIOUS DISEASE TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL OSTEOPOROSIS TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL SEXUALLY TRANSMITTED DISEASE TESTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL WOMEN'S OTHER HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 16. GLOBAL WOMEN'S HEALTH DIAGNOSTICS IN HOME CARE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 17. GLOBAL WOMEN'S HEALTH DIAGNOSTICS IN HOSPITALS & CLINICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 18. GLOBAL WOMEN'S HEALTH DIAGNOSTICS IN DIAGNOSTIC AND IMAGING CENTERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 19. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 20. US WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. UK WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. FRANCE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. GERMANY WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. ITALY WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. SPAIN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. REST OF EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 31. SOUTH KOREA WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 32. REST OF ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 33. REST OF THE WORLD WOMEN'S HEALTH DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
目次
Product Code: OMR2026422

Global Women's Health Diagnostics Market Size, Share & Trends Analysis Report by Diagnostic Devices(Biopsy Devices, and Tests) by Application (Breast Cancer Testing, PAP Smear (PAP) and HPV Test, Infectious Disease Testing, Osteoporosis Testing, Pregnancy, and Fertility Testing, Sexually Transmitted Disease Testing, and Others) and by End User (Home Care, Hospitals & Clinics, and Diagnostic and Imaging Centers) Forecast Period (2022-2028)

The global women's health diagnostics market is anticipated to grow at a substantial CAGR of 7.5% during the forecast period. An increasing investments initiatives by key players are accepted to contribute to the growth of the market. Moreover, such initiatives are greater in the availability of more comfortable and convenient option that leads to great adoption of medical devices. For instance, in March 2022, Willow launched a new cord-free smart breast pump. It is priced at $329 and will be available with insurance plans that offer breast pumps for free or at a reduced cost, many will only cover the cost of a manual breast pump.

The global women's health diagnostics market is segmented based on diagnostic devices, application, and end-user. Based on diagnostic devices, the market is segmented into biopsy devices and tests. Based on the application, the market is sub-classified into cancer testing, PAP smear (PAP) and HPV test, infectious disease testing, osteoporosis testing, pregnancy, and fertility testing, sexually transmitted disease testing, and others. Based on the end-user, the market is sub-divided into home care, hospitals & clinics, and diagnostic and imaging centers. Among the end-user segment, the hospitals & clinics segment is dominating owing to the high number of patients visits and rising diagnostic procedures related to women health.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is likely to dominate the market during the forecast period. The regional growth is attributed to the presence of better healthcare infrastructure, and increased women's major health issues which is positively influencing the region's markets growth. Moreover, regulatory approval from the government authority is also propelling the growth of the market in North America. For instance, in January 2021, the Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has approved Seno Medical Instruments Inc., for its Imagio Breast Imaging System. This system is groundbreaking diagnostic breast cancer imaging technology, and it will help physicians better differentiate between benign and malignant breast lesions.

The major companies serving the global women's health diagnostics market include F. Hoffmann-La Roche Lt, General Electric Co., Hologic Inc., Myriad Genetics, Inc., MedGyn Products Inc., and PerkinElmer Inc., Siemens Medical Solutions USA, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, Abbott has acquired Walk Vascular, to expand its peripheral vascular offerings. The peripheral thrombectomy systems of Walk Vascular will be integrated into the endovascular products portfolio. Moreover, Walk Vascular JETi Peripheral Thrombectomy System and JETi AIO (All In One) Peripheral Thrombectomy System are systems that are used to remove intravascular clots known as thrombus.

Research Methodology

The market study of the global women's health diagnostics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Women's Health Diagnostics Market Research and Analysis by Device

2. Global Women's Health Diagnostics Market Research and Analysis by Test

3. Global Women's Health Diagnostics Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive Research Methodology of the global women's health diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global women's health diagnostics market.
  • Insights about market determinants that are stimulating the global women's health diagnostics market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Women's Health Diagnostics Market
  • Recovery Scenario of Global Women's Health Diagnostics Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. F. Hoffmann-La Roche Ltd
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. General Electric Co.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Hologic, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. PerkinElmer Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Siemens Medical Solutions USA, Inc.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis
  • 3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Women's Health Diagnostics Market by Type
    • 4.1.1. Diagnostic Devices
    • 4.1.2. Diagnostic Tests
  • 4.2. Global Women's Health Diagnostics Market by Application
    • 4.2.1. Breast Cancer Testing
    • 4.2.2. PAP Smear (PAP) and HPV Test
    • 4.2.3. Infectious Disease Testing
    • 4.2.4. Osteoporosis Testing
    • 4.2.5. Pregnancy and Fertility Testing
    • 4.2.6. Sexually Transmitted Disease Testing
    • 4.2.7. Other
  • 4.3. Global Women's Health Diagnostics Market by End-User
    • 4.3.1. Home Care
    • 4.3.2. Hospitals & Clinics
    • 4.3.3. Diagnostic and Imaging Centers

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. US
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

 

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. Becton, Dickinson and Co
  • 6.3. BIOMERIEUX, INC.
  • 6.4. Bio-Rad Laboratories, Inc.
  • 6.5. BOSTON IMAGING
  • 6.6. Canon Medical Systems Corp.
  • 6.7. Carestream Health, Inc.
  • 6.8. Cook Group Inc
  • 6.9. DiaSorin S.p.A
  • 6.10. Grifols, S.A.
  • 6.11. Konica Minolta Healthcare Americas, Inc.
  • 6.12. Laboratory Corp.
  • 6.13. Myriad Genetics, Inc.
  • 6.14. MedGyn Products, Inc.
  • 6.15. Ortho Clinical Diagnostics
  • 6.16. Philips International B.V.,
  • 6.17. Quest Diagnostics
  • 6.18. Thermo Fisher Scientific Inc.
  • 6.19. Ziehm Imaging GmbH